Drugs / I-LV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01321957 Comparator | May 2011 → Sep 2016 | colorectal cancer | Martin-Luther-University Halle-Wittenberg | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | I-LV | “I-LV at a dose of 200 mg/m2 iv over two hours (day 1)” NCT01321957 ↗ |
| Route | Intravenous | “I-LV at a dose of 200 mg/m2 iv over two hours (day 1)” NCT01321957 ↗ |